Literature DB >> 8496198

Innovations in surgery. A proposal for phased clinical trials.

M Gross1.   

Abstract

There is an urgent need for the staged, controlled, introduction of new technology and new procedures to surgery. A classification system in four stages is proposed, which would allow for prospective assessment of new devices or methods before they are released for use by the surgical community. The proposal recognises the unique nature of a surgical operation and its learning curve. The issues of randomisation and of informed consent are discussed, and are shown not to be barriers to clinical trials, but necessary adjuncts to orderly testing. The importance of continued surveillance of innovations is emphasised.

Mesh:

Year:  1993        PMID: 8496198     DOI: 10.1302/0301-620X.75B3.8496198

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  5 in total

Review 1.  [Application of the da Vinci robotic system in thoracic surgery].

Authors:  M Ismail; M Swierzy; M Ulrich; J C Rückert
Journal:  Chirurg       Date:  2013-08       Impact factor: 0.955

Review 2.  State of the art of robotic thymectomy.

Authors:  Mahmoud Ismail; Marc Swierzy; Jens C Rückert
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

3.  EAES recommendations on methodology of innovation management in endoscopic surgery.

Authors:  Edmund A M Neugebauer; Monika Becker; Gerhard F Buess; Alfred Cuschieri; Hans-Peter Dauben; Abe Fingerhut; Karl H Fuchs; Brigitte Habermalz; Leonid Lantsberg; Mario Morino; Stella Reiter-Theil; Gabriela Soskuty; Wolfgang Wayand; Thilo Welsch
Journal:  Surg Endosc       Date:  2010-01-07       Impact factor: 4.584

4.  Learning curves in hip fracture surgery.

Authors:  Kristian Bjorgul; Wendy M Novicoff; Khaled J Saleh
Journal:  Int Orthop       Date:  2010-02-20       Impact factor: 3.075

Review 5.  Adaption and application of the four phase trials to traditional chinese medicines.

Authors:  M Y Di; J L Tang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.